Hydroxytyrosol inhibits pro-inflammatory cytokines, iNOS, and COX-2 expression in human monocytic cells

被引:130
|
作者
Zhang, Xiaomei [2 ,3 ]
Cao, Jun [3 ]
Zhong, Laifu [1 ,3 ]
机构
[1] Dalian Med Univ, Dept Toxicol, Dalian 116044, Peoples R China
[2] Dalian Univ Technol, Dept Lab Med, Coll Med, Dalian 116622, Liaoning, Peoples R China
[3] Dalian Med Univ, Dept Toxicol, Dalian 116027, Liaoning, Peoples R China
基金
中国国家自然科学基金;
关键词
Hydroxytyrosol; iNOS; COX-2; THP-1; cells; NITRIC-OXIDE SYNTHASE; (-)-EPIGALLOCATECHIN-3-GALLATE BLOCKS; OLIVE OIL; CYCLO-OXYGENASE-2; CYCLOOXYGENASE-2; ACTIVATION; COMPOUND;
D O I
10.1007/s00210-009-0399-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hydroxytyrosol (HT), isolated from extra-virgin olive oil, possesses a marked antioxidant activity and is a good radical scavenger. In this study, our aim was to examine the anti-inflammatory mechanism of HT through measuring the inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2) expression, TNF-alpha formation, and nitric oxide (NO) release in lipopolysaccharide (LPS)-induced human monocytic (THP-1) cells. Results showed that HT remarkably suppressed the LPS (1 mu g/ml) induction of NO release. It also significantly attenuated the LPS-induced transcription of TNF-alpha, iNOS, and COX-2 in a dose-dependent manner. Furthermore, it was also found that HT in a concentration-dependent manner inhibited the expression of iNOS and COX-2 in THP-1 cells treated with 1 mu g/ml LPS using Western Blot. Taken together, these results suggest that HT exerts anti-inflammatory effects probably through the suppression of COX-2 and iNOS expression.
引用
收藏
页码:581 / 586
页数:6
相关论文
共 50 条
  • [1] Hydroxytyrosol inhibits pro-inflammatory cytokines, iNOS, and COX-2 expression in human monocytic cells
    Xiaomei Zhang
    Jun Cao
    Laifu Zhong
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2009, 379
  • [2] Tetrandrine inhibits proinflammatory cytokines, iNOS and COX-2 expression in human monocytic cells
    Wu, Shu-Jing
    Ng, Lean-Teik
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2007, 30 (01) : 59 - 62
  • [3] Modulation of the activity of pro-inflammatory enzymes, COX-2 and iNOS, by chrysin derivatives
    Cho, HY
    Yun, CW
    Park, WK
    Kong, JY
    Kim, YS
    Park, YM
    Lee, SY
    Kim, BK
    PHARMACOLOGICAL RESEARCH, 2004, 49 (01) : 37 - 43
  • [4] Modulation of COX-2 expression by statins in human monocytic cells
    Habib, Aida
    Shamseddeen, Ishraq
    Nasrallah, Mona S.
    Antoun, Tania Abi
    Nemer, Georges
    Bertoglio, Jacques
    Badreddine, Rami
    Badr, Kamal F.
    FASEB JOURNAL, 2007, 21 (08): : 1665 - 1674
  • [5] INTERACTIONS BETWEEN PRO-INFLAMMATORY AND IMMUNOREGULATORY CYTOKINES MODULATE THE EXPRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS IN MONOCYTIC CELLS
    POLI, G
    KINTER, AL
    WEISSMAN, D
    BISWAS, P
    FAUCI, AS
    CLINICAL RESEARCH, 1993, 41 (02): : A137 - A137
  • [6] Effects of pro-inflammatory cytokines, lipopolysaccharide and COX-2 mediators on human colonic neuromuscular function and epithelial permeability
    Safdari, B. K.
    Sia, T. C.
    Wattchow, D. A.
    Smid, S. D.
    CYTOKINE, 2016, 83 : 231 - 238
  • [7] Brown alga Sargassum muticum inhibits proinflammatory cytokines, iNOS, and COX-2 expression in macrophage RAW 264.7 cells
    Yoon, Weon-Jong
    Ham, Young Min
    Lee, Wook Jae
    Lee, Nam Ho
    Hyun, Chang-Gu
    TURKISH JOURNAL OF BIOLOGY, 2010, 34 (01) : 25 - 34
  • [8] Tinospora cordifolia extract modulates COX-2, iNOS, ICAM-1, pro-inflammatory cytokines and redox status in murine model of asthma
    Tiwari, M.
    Dwivedi, U. N.
    Kakkar, P.
    JOURNAL OF ETHNOPHARMACOLOGY, 2014, 153 (02) : 326 - 337
  • [9] Acacia ferruginea inhibits inflammation by regulating inflammatory iNOS and COX-2
    Sakthivel, Kunnathur Murugesan
    Guruvayoorappan, Chandrasekaran
    JOURNAL OF IMMUNOTOXICOLOGY, 2016, 13 (01) : 127 - 135
  • [10] Bergapten inhibits chemically induced nociceptive behavior and inflammation in mice by decreasing the expression of spinal PARP, iNOS, COX-2 and inflammatory cytokines
    Singh, Gurjit
    Kaur, Anudeep
    Kaur, Jashanpreet
    Bhatti, Manpreet S.
    Singh, Palwinder
    Bhatti, Rajbir
    INFLAMMOPHARMACOLOGY, 2019, 27 (04) : 749 - 760